Evercore ISI bumped its price target on Cardinal Health (NYSE: CAH) modestly to $78.00 (from $77.50) while maintaining a Outperform rating following Q1 results.

Analyst Ross Muken said while the company didn't have any new surprises, they view Pharma momentum as slightly above expectation and Medical likely a touch below. He alsos said the MDT acquisition remains somewhat underappreciated.

The firm trimmed FY 2017 EPS from $5.40 to $5.35, and raised FY 2018 EPS from $5.25 to $5.30. FY 2019 was maintained at $5.85.